newsfilter
← Latest News
GlobeNewswire·

Instil Bio Announces Appointment of Tim Moore as Chief Operating Officer

DALLAS, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Instil Bio, Inc. ("Instil") (NASDAQ:TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today anno